AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Brest
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to demonstrate that simulation training for paramedical staff in neurosurgery departments, in announcing and accompanying patients with a brain tumor, improves patient satisfaction when a (potentially malignant) brain tumor is discovered, compared with usual care. The main question it aims to answer is: \- Are patients more satisfied (as measured by scores on the EORCT IN-PATSAT32 questionnaire) with their neurosurgical hospitalization following the discovery of a brain tumor in centers where paramedics have been trained by simulation? Researchers will compare the results of the EORTC IN-PATSAT32 questionnaire to determine whether paramedic training improves patient satisfaction between simulation-trained and untrained centers. Participants will be asked to complete the EORT IN-PATSAT32 questionnaire at the end of their hospital stay.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient over 18 years of age * Patient covered by a social security scheme * Patient signed informed consent form * Patient found to have a brain tumor (potentially malignant, primary or secondary if this is the mode of entry into the disease) * Hospitalization in the Neurosurgery Department at the time of tumor discovery, before the histological diagnosis is announced. Exclusion Criteria: * Patients with a personal history of cancer * Patient without family AND unable to receive information
๐Ÿ’Š

What it tests

  • Paramedic training
๐Ÿ“

Where

11 sites
CHU Brest
Brest, France
CHU Amiens
Amiens, France
CHU Angers
Angers, France
CHU Bordeaux
Bordeaux, France
APHM Nord
Marseille, France
CHU Nantes
Nantes, France
CHU Nice
Nice, France
CHU Rouen
Rouen, France

โ€ฆand 3 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy